Edelweiss Short Term Income Fund Institutional (Ex) - IDCW Reinvestment
Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Debt, Short Term(Old), Principal at moderately low risk
1 Year Return 0.0% at 22 Dec 2025 06:23 PM
Fund Details
NAV 10.562
Sub-Type Short Term(Old)
Rating Not Rated
Min. SIP Amount ₹500.0
Fund Age(Year) 17.24
Fund Size(in Crores) 0
Fund Performance
1 Month 0.0%
3 Month 0.0%
6 Month 0.0%
1 Year 0.0%
3 Year 0.0%
5 Year 0.0%
Know This Fund
As on 22 Dec 2025
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.75%) Market Cap Mid Cap 27.11 Large Cap 20.74 Small Cap 50.9 Top Sectors Healthcare 98.75 Top Holding Divi's Laboratories 2.88 Dr. Reddy's Laboratories 3.74 Ipca Laboratories 2.03 Laxmi Dental 0.37 Torrent Pharmaceuticals 0.96 Acutaas Chemicals 1.03 Dr. Lal Pathlabs 0.54 Emcure Pharmaceuticals 0.94 Ajanta Pharma 6.48 Krishna Institute 2.15 Alkem Laboratories 3.43 Anthem Biosciences 1.7 Biocon 1.06 Orchid Pharma 0.74 Cipla 3.4 Jupiter Life Line Hospitals 2.98 Syngene International 1.04 Aurobindo Pharma 2.72 Metropolis Healthcare 1.66 Glenmark Pharmaceuticals 4.06 Alembic Pharmaceuticals 0.88 Procter & Gamble Health 3.41 Sanofi Consumer Healthcare India 1 Jubilant Pharmova 0.87 Apollo Hospitals Enterprise 3.45 Windlas Biotech 1.09 Sai Life Sciences 1.8 Pfizer 1.71 Sudeep Pharma 1.41 Fortis Healthcare 2.29 Global Health 1.88 Sequent Scientific 1.73 Lupin 5.91 Sun Pharmaceutical Industries 9.76 Max Healthcare Institute 2.48 Rainbow Children's 0.94 Caplin Point Laboratories 2.22 Eris Lifesciences 2.49 Vijaya Diagnostic Centre 1.06 Gland Pharma 3.46 Cohance Lifesciences 1.93 Marksans Pharma 1.26 Aster DM Healthcare 1.8
Debt & Others (1.25%) Sector Allocation CBLO 0.01 Net Current Assets 1.24 Debt Credit Ratings Debt Category Others 1.25
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -1.66% Ret 1Y -1.96% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -2.13% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 0%
Exit Load 0%
Stamp Duty 0%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at moderately low risk
AMC and Fund details
Rank (total sets) 0
Date of Incorporation 2008-09-26
Total AUM 2025-11-30
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.